This Biopharmaceutical Stock Looks Like a Steal

Shares of Evofem Biosciences Inc. tumbled 24.9% toward a record low in premarket trading Thursday, after the biopharmaceutical company focused on women's sexual and reproductive health announced .....»»

Shares of Immunome Inc. blasted 212.6% higher toward new highs Thursday, to pace all of the premarket gainers trading on major U.S. exchanges, after biopharmaceutical company said it.....»»

Shares of Heat Biologics Inc. more than doubled in very active trading Tuesday, after the biopharmaceutical company focused on modulating the immune system reported "positive" in.....»»

Shares of Ocugen Inc. more than tripled on massive volume Monday, after the biopharmaceutical company working on a treatment for blindness and a potential COVID-19 vaccine announced a direct offer.....»»

Shares of Immunovant Inc. plunged 49.8% to pace all premarket losers Tuesday, after the biopharmaceutical company said it has paused dosing in its phase 2b trial for IMVT.....»»

Arcus Biosciences Inc. disclosed Monday that Gilead Sciences Inc. boosted its stake in the oncology-focused biopharmaceutical company, through the purchase of $220.35 million worth of stock. Arcus shares were still inactive in pr.....»»

Aclaris Therapeutics has priced a planned $96 million stock sale, a day after shares of the firm soared to a nearly two-and-a-half-year high. The Wayne biopharmaceutical company's stock shot up more than 220% after it announced positive mid-stag.....»»

Two Philadelphia-area biopharmaceutical companies focused on developing cancer therapies expect to raise a total of nearly $160 million from stock offerings Monday. The majority of the funds are expected to be raised by Prelude Therapeutics (NAS.....»»

Shares of Veru Inc. soared 51.4% toward a seven-year high on massive volume, after the biopharmaceutical company announced positive results from a Phase 2 study of its treatment.....»»

Shares of Sorrento Therapeutics Inc. blasted 153% higher on very heavy volume in afternoon trading Friday, putting it on track to close at a near 2-year high, after the biopharmaceutical company provided an upb.....»»

Shares of Portola Pharmaceuticals Inc. more than doubled in very active morning trading Tuesday, after the biopharmaceutical company focuse.....»»

Inovio Pharmaceuticals Inc. plans to begin human testing of its coronavirus vaccine candidate Monday — making it among the first biopharmaceutical companies to accomplish that goal. The Plymouth Meeting company's stock was trading up more than 3% at $7.....»»

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors looking to time th.....»»

Consumers are warned that they could soon be inundated with fake products, phony stock deals, fabricated emails, and more that are des.....»»

Shares of Brickell Biotech Inc. were vaulted 61% higher on very heavy volume, putting them on track for the biggest one-day gain since the biopharmaceutical company went public 27 years ago, after.....»»

Maryland biopharmaceutical company Cerecor has completed its acquisition of Wayne-based Aevi Genomic Medicine, Inc. in a transaction involving two companies both focused on developing new therapies for rare pediatric diseases. The all-stock deal, fi.....»»

Annovis Bio went public Wednesday, raising $12 million through its initial public stock offering. The Berwyn biopharmaceutical company, which is developing treatments for neurological disorders including Parkinson's and Alzheimer's diseases, sold two mi.....»»

Biopharmaceutical company Durect Corp.'s shares slid 12% in premarket trade Friday, after a U......»»

Paratek Pharmaceuticals's stock closed up 32% Thursday after the biopharmaceutical company announced it was awarded a five-year contract worth up to $285 million from the federal government. The funds will support the development of the company's a.....»»

Shares of Proteostasis Therapeutics Inc. fell 35% in premarket trading on Tuesday after the biopharmaceutical company shared mixed findings from a mid-stage study for its experi.....»»